Related Experiment Video
Updated: Mar 6, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Pregnancy in women with hypertrophic cardiomyopathy
1From the Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.
Insights
Pregnancy in women with hypertrophic cardiomyopathy (HCM) has low maternal mortality (0.5%). Most pregnancies are uneventful, but risks like premature birth (26%) are increased for both mother and fetus.
Area of Science:
- Cardiology
- Maternal-Fetal Medicine
- Genetics
Background:
- Pregnancy significantly stresses the cardiovascular system.
- Pre-existing heart conditions, like hypertrophic cardiomyopathy (HCM), increase risks during pregnancy.
- Maternal mortality and adverse fetal outcomes are concerns in high-risk pregnancies.
Purpose of the Study:
- To review maternal and fetal outcomes of pregnancy in women with hypertrophic cardiomyopathy (HCM).
- To identify complications associated with pregnancy in HCM patients.
- To provide an evidence-based overview for managing these pregnancies.
Main Methods:
- Systematic literature review of MEDLINE database.
- Inclusion of cohort design studies reporting pregnancy outcomes in HCM.
- Pooled analysis of data from 11 studies (9 cohorts, 237 women, 408 pregnancies).
Main Results:
- Most pregnancies in women with HCM were uneventful.
- Maternal mortality rate was 0.5%, primarily in high-risk individuals.
- Complications or symptom worsening occurred in 29% of patients.
- Fetal risks included spontaneous abortion (15%), therapeutic abortion (5%), stillbirth (2%), and premature birth (26%).
Conclusions:
- Pregnancy in women with HCM carries low maternal mortality, concentrated in high-risk profiles.
- Fetal mortality rates are comparable to the general population.
- Increased risk of premature birth is a significant concern in HCM pregnancies.
Abstract:
Pregnancy places a significant burden on the cardiovascular system and may lead to heart failure, arrhythmias, and, rarely, maternal mortality in women with pre-existent heart disease. The objective of this review was to provide an overview of maternal and fetal outcomes and complications of pregnancy in women with hypertrophic cardiomyopathy (HCM). A systematic review of the literature in the MEDLINE database was performed to identify cohort design studies reporting outcome and complications of pregnancy in HCM. The literature search returned 11 studies on 9 patient cohorts reporting the outcome and complications of pregnancy in HCM. In case of >1 publication on a particular cohort, the most recent publication was included in the analysis. A pooled analysis of the outcome data was performed, and weighted event rates and 95% confidence intervals were calculated. The analysis of data from 9 cohorts, including 237 women and 408 pregnancies, demonstrated that most pregnancies in women with HCM are uneventful. Still, pregnancy in women with HCM carries maternal and fetal risks. The maternal mortality rate was 0.5%, and any complication or worsening of symptoms occurred in 29% of the patients. Fetal mortality was caused by spontaneous abortion (15%), therapeutic abortion (5%), and stillbirth (2%). Premature birth was observed in 26%. In conclusion, maternal mortality related to pregnancy in women with HCM is low and appears to be confined to women with a high-risk profile before pregnancy. Fetal mortality is comparable to that in the general population; however, the risk of premature birth is increased.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Mitral Valve Prolapse III: Nursing Management

